Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen

By Mahendra Kumar Trivedi1, Alice Branton1, Dahryn Trivedi1, Gopal Nayak1, Harish Shettigar1, Sambhu Charan Mondal2, Snehasis Jana2

1. Trivedi Global Inc. 2. Trivedi Science Research Laboratory Pvt. Ltd.

Published on

Abstract

Streptococcus agalactiae group B (S. agalactiae gr. B) is widespread in nature mainly causes bacterial septicemia and neonatal meningitis. The current study was attempted to investigate the effect of biofield treatment on S. agalactiae gr. B with respect of antimicrobial sensitivity, biochemical reactions and bio typing. S. agalactiae gr. B strain was used in this experiment bearing the American Type Culture Collection (ATCC 12386) number and stored according to the recommended storage protocol. The revived and lyophilized state of ATCC strains of S. agalactiae gr. B were selected for the study. Gr. I was considered as control. Both revived (Group; Gr. II) and lyophilized (Gr. III) strains of S. agalactiae gr. B were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10 while Gr. III on day 10 with respect to the control (Gr. I) using MicroScan Walk-Away® system. Although biofield treatment did not show any change with respect to susceptibility pattern. However the minimum inhibitory concentration of S. agalactiae gr. B showed significant (70.37%) alteration, out of twenty-seven tested antimicrobials, among which in Gr. II i.e. 62.96% on day 5 and 66.67% on day 10 while no alteration was found in lyophilized group (Gr. III) as compared to the control. Moreover, the improvement of MIC value of norfloxacin was observed by two-fold (8 to ≤4 µg/mL) in Gr. II on day 10 after biofield energy treatment as compared to the control. It was observed that overall 48.28% biochemical reactions, out of twenty-nine were altered in Gr. II with respect to the control. Moreover, biotype numbers were changed in Gr. II on day 5 (777777615) and on day 10 (757677405) as compared to the control (237147047). The results suggest that biofield treatment has significant impact on S. agalactiae gr. B in revived treated cells (Gr. II) with respect to MIC values, biochemical reactions pattern and biotype number.

References

1. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, et al. (2000) Group B Streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 96: 498-503.

2. Cowgill K, Taylor TH Jr, Schuchat A, Schrag S (2003) Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. J Womens Health (Larchmt) 12: 527-532.

3. Mullaney DM (2001) Group B streptococcal infections in newborns. J Obstet Gynecol Neonatal Nurs 30: 649-658.

4. van der Poll T, Opal SM (2008) Host-pathogen interactions in sepsis. Lancet Infect Dis 8: 32-43.

5. Ratner HB, Weeks LS, Stratton CW (1986) Evaluation of spot CAMP test for identification of group B streptococci. J Clin Microbiol 24: 296-297.

6. Schuchat A, Wenger JD (1994) Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev 16: 374-402.

7. Jacobs MR, Kelly F, Speck WT (1982) Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 22: 897-900.

8. McCracken GH Jr, Ginsberg C, Chrane DF, Thomas ML, Horton LJ (1973) Clinical pharmacology of penicillin in newborn infants. J Pediatr 82: 692-698.

9. Myers R (2003) The basics of chemistry. Greenwood Press, Westport, Connecticut.

10. Movaffaghi Z, Farsi M (2009) Biofield therapies: biophysical basis and biological regulations? Complement Ther Clin Pract 15: 35-37.

11. Rivera-Ruiz M, Cajavilca C, Varon J (2008) Einthoven's string galvanometer: the first electrocardiograph. Tex Heart Inst J 35: 174-178.

12. Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal powder characteristics. Met Powder Rep 63: 22-28, 31.

13. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after Biofield treatment. Ind Eng Manage 4: 161.

14. Dabhade VV, Tallapragada RR, Trivedi MK (2009) Effect of external energy on atomic, crystalline and powder characteristics of antimony and bismuth powders. Bull Mater Sci 32: 471-479.

15. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of biofield treatment on ginseng and organic blueberry yield. Agrivita J Agric Sci 35: 22-29.

16. Lenssen AW (2013) Biofield and fungicide seed treatment influences on soybean productivity, seed quality and weed community. Agricultural Journal 83: 138-143.

17. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial sensitivity pattern of Pseudomonas fluorescens after biofield treatment. J Infect Dis Ther 3: 222.

18. Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment. J Microb Biochem Technol 7: 203-206.

19. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) An effect of biofield treatment on multidrug-resistant Burkholderia cepacia: A multihost pathogen. J Trop Dis 3: 167.

20. Patil SA, Nayak GB, Barve SS, Tembe RP, Khan RR (2012) Impact of biofield treatment on growth and anatomical characteristics of Pogostemon cablin (Benth.). Biotechnology 11: 154-162.

21. Nayak G, Altekar N (2015) Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9.

22. Fader RC, Weaver E, Fossett R, Toyras M, Vanderlaan J, et al. (2013) Multilaboratory study of the biomic automated well-reading instrument versus MicroScan WalkAway for reading MicroScan antimicrobial susceptibility and identification panels. J Clin Microbiol 51: 1548-1554.

23. Kaufhold A, Ferrieri P (1993) The microbiologic aspects, including diagnosis, of beta-hemolytic streptococcal and enterococcal infections. Infect Dis Clin North Am 7: 235-256.

24. Facklam RR, Thacker LG, Fox B, Eriquez L (1982) Presumptive identification of streptococci with a new test system. J Clin Microbiol 15: 987-990.

25. Ekin IH, Gurturk K, Yaman G, Yesilova A (2010) Biotyping of nontypeable Group B Streptococci. Van Vet J 21: 117-122.

26. Lindstrom E, Mild KH, Lundgren E (1998) Analysis of the T cell activation signaling pathway during ELF magnetic field exposure, p56lck and [Ca2+]i-measurements. Bioeletrochem Bioenerg 46: 129-137.

Cite this work

Researchers should cite this work as follows:

  • Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
     

  • Mahendra Kumar Trivedi; Alice Branton; Dahryn Trivedi; Gopal Nayak; Harish Shettigar; Sambhu Charan Mondal; Snehasis Jana (2019), "Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen," https://diagrid.org/resources/1399.

    BibTex | EndNote

Tags